Keyphrases
Glioblastoma Cells
100%
Transdifferentiation
100%
Tumor Endothelial Cells
100%
Vascular Endothelial Cells
100%
Anti-VEGF Therapy
75%
Endothelial Cells
50%
Tumor Cells
50%
Glioblastoma
50%
Hippocampus
25%
Tumor
25%
Cell-to-cell
25%
Transplantation
25%
Hypoxia
25%
Combination Therapy
25%
Human Glioblastoma
25%
Oncogene
25%
In Vitro Differentiation
25%
Primary Brain Tumor
25%
Cre Recombinase
25%
Cell Fusion
25%
Resistance Mechanisms
25%
Glioblastoma Therapy
25%
Xenograft Model
25%
Endothelial Tumors
25%
Clinical Samples
25%
Cell Formation
25%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
25%
Heterozygous Mice
25%
Lentiviral Vector
25%
Differentiation Assay
25%
Cre Mice
25%
Tumor-initiating Cells
25%
Clinical Specimens
25%
GFAP-Cre
25%
VEGF Receptor Inhibitor
25%
Medicine and Dentistry
Endothelial Cell
100%
Glioblastoma
100%
Vascular Endothelial Cell
100%
Cell Transdifferentiation
100%
Neoplasm
83%
Vasculotropin
66%
Tumor Cell
33%
Cre Recombinase
33%
In Vitro
16%
Xenograft
16%
Hypoxia
16%
Combination Therapy
16%
Hippocampus
16%
Protein P53
16%
Oncogene
16%
Cancer Stem Cell
16%
Brain Cancer
16%
Vasculotropin Receptor
16%
Cell Fusion
16%
Lentivirus Vector
16%
Immunology and Microbiology
Vasculotropin
100%
Vascular Endothelial Cell
100%
Cell Transdifferentiation
100%
Mouse
80%
Tumor Cell
40%
Hippocampus
20%
Xenograft
20%
P53
20%
Oncogene
20%
Cancer Stem Cell
20%
Cell Fusion
20%
Lentivirus Vector
20%
Biochemistry, Genetics and Molecular Biology
Mouse
100%
Vascular Endothelial Growth Factor
100%
Transdifferentiation
100%
Cre Recombinase
50%
P53
25%
Cancer Stem Cell
25%
Oncogene
25%
Cell Fusion
25%
Lentivirus Vector
25%
VEGF Receptors
25%
Neuroscience
Vascular Endothelial Growth Factor
100%
Cell Transdifferentiation
100%
Cre Recombinase
50%
Hippocampus
25%
In Vitro
25%
P53
25%
Brain Tumor
25%
Cancer Stem Cell
25%
Oncogene
25%
Cell Fusion
25%
Lentivirus Vector
25%
VEGF Receptors
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Neoplasm
100%
Mouse
50%
Vasculotropin
50%
Cre Recombinase
25%
Combination Therapy
12%
Hypoxia
12%
Protein P53
12%
Brain Cancer
12%
Vasculotropin Receptor
12%
Lentivirus Vector
12%